Evidence map›Paper›PMID 28250123›Full record

ArticleJournal of virology2017

Influenza A Virus Virulence Depends on Two Amino Acids in the N-Terminal Domain of Its NS1 Protein To Facilitate Inhibition of the RNA-Dependent Protein Kinase PKR.

Kristina L Schierhorn, Fabian Jolmes, Julia Bespalowa, Sandra Saenger, Christin Peteranderl, Julia Dzieciolowski, Maja Mielke, Matthias Budt, Stephan Pleschka, Andreas Herrmann and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Article
  3. ISG20 RestrictsMicroorganisms · 2025
    Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Viral evasion of PKR restriction by reprogramming cellular stress granules.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Immunity to Influenza Infection in Humans.Cold Spring Harbor perspectives in medicine · 2021
    Review
  18. Arginine depletion as a therapeutic approach for patients with COVID-19.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2021
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Kristina L SchierhornUnit 17, Influenza and other Respiratory Viruses, Robert Koch Institut, Berlin, Germany.
Fabian JolmesDepartment of Biology, Molecular Biophysics, IRI Life Sciences, Humboldt Universität zu Berlin, Berlin, Germany.
Julia BespalowaUniversities Giessen & Marburg Lung Center, Department of Internal Medicine II, Section of Infectious Diseases, German Center for Lung Research, Giessen, Germany.
Sandra SaengerUnit 17, Influenza and other Respiratory Viruses, Robert Koch Institut, Berlin, Germany.
Christin PeteranderlUniversities Giessen & Marburg Lung Center, Department of Internal Medicine II, Section of Infectious Diseases, German Center for Lung Research, Giessen, Germany.
Julia DzieciolowskiInstitute of Medical Virology, Justus Liebig University Giessen, Giessen, Germany.
Maja MielkeDepartment of Biology, Molecular Biophysics, IRI Life Sciences, Humboldt Universität zu Berlin, Berlin, Germany.
Matthias BudtUnit 17, Influenza and other Respiratory Viruses, Robert Koch Institut, Berlin, Germany.
Stephan PleschkaInstitute of Medical Virology, Justus Liebig University Giessen, Giessen, Germany.
Andreas HerrmannDepartment of Biology, Molecular Biophysics, IRI Life Sciences, Humboldt Universität zu Berlin, Berlin, Germany.
Susanne HeroldUniversities Giessen & Marburg Lung Center, Department of Internal Medicine II, Section of Infectious Diseases, German Center for Lung Research, Giessen, Germany.
Thorsten WolffUnit 17, Influenza and other Respiratory Viruses, Robert Koch Institut, Berlin, Germany wolfft@rki.de.
Robert Koch Institute · DEHumboldt-Universität zu Berlin · DEJustus-Liebig-Universität Gießen · DEUniversities of Giessen and Marburg Lung Center · DEGerman Center for Lung Research · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The RNA-dependent protein kinase (PKR) has broad antiviral activity inducing translational shutdown of viral and cellular genes and is therefore targeted by various viral proteins to facilitate pathogen propagation. The pleiotropic NS1 protein of influenza A virus acts as silencer of PKR activation and ensures high-level viral replication and virulence. However, the exact manner of this inhibition remains controversial. To elucidate the structural requirements within the NS1 protein for PKR inhibition, we generated a set of mutant viruses, identifying highly conserved arginine residues 35 and 46 within the NS1 N terminus as being most critical not only for binding to and blocking activation of PKR but also for efficient virus propagation. Biochemical and Förster resonance energy transfer (FRET)-based interaction studies showed that mutation of R35 or R46 allowed formation of NS1 dimers but eliminated any detectable binding to PKR as well as to double-stranded RNA (dsRNA). Using

Indexed as

Amino AcidsAnimalsCell LineeIF-2 KinaseEnzyme ActivationHost-Pathogen InteractionsHumansImmunity, InnateInfluenza A virusLungMiceMutationViral Nonstructural ProteinsVirulenceVirus ReplicationAmino AcidseIF-2 KinaseINS1 protein, influenza virusViral Nonstructural Proteinsinfluenzainnate immunityPKRvirulence regulation

Identifiers

PMID28250123
PMCPMC5411612
OpenAlexW2591887241

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.